Cardiovascular Disease

Merck’s Enlicitide: Breakthrough Oral Pill Dramatically Lowers Cholesterol New Orleans, LA – A groundbreaking new oral medication developed by Merck has demonstrated …

Gene Editing for Cholesterol: The Dawn of ‘One-and-Done’ Cardiovascular Care Nearly 39% of U.S. adults aged 20 or older have high cholesterol …

Repatha Injection Significantly Reduces Cardiovascular Risk in High-Risk Patients New Orleans, LA – A groundbreaking study presented at the American Heart Association’s …

Heart Health in Midlife: A Critical Predictor of Later-Life Dementia Risk New research underscores a concerning link between cardiovascular health during middle …

Viral Threat to the Heart: Common Infections Linked to Increased Stroke and Heart Attack Risk A sweeping global review has revealed a …

The Vascular Shield: How Flavonol-Rich Foods Combat the Health Risks of Prolonged Sitting The modern world demands extended periods of sitting – …

Silent Surge: How Early Menopause is Reshaping the Cardiovascular Risk Landscape for Women Nearly one in ten women experience menopause before age …

Nearly half of the world’s population now lives under light-polluted skies. But the consequences extend far beyond obscuring the stars. A groundbreaking …

Obesity Rates in the US Poised for Dramatic Increase, New Study Reveals A groundbreaking study from Mass General Brigham suggests that obesity …

Nearly 99.6% of heart attacks are preceded by at least one detectable risk factor. That startling statistic, emerging from a massive global …